SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-016175
Filing Date
2020-06-29
Accepted
2020-06-29 18:39:34
Documents
7
Period of Report
2020-06-29

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea123551-6k_canfitebiopharma.htm 6-K 14704
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S SPECIAL MEETING OF SHAR ea123551ex99-1_canfitebio.htm EX-99.1 65149
3 PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S SPECIAL ea123551ex99-2_canfitebio.htm EX-99.2 19703
4 VOTING INSTRUCTION CARD FOR AMERICAN DEPOSITARY SHARE HOLDERS WITH RESPECT TO TH ea123551ex99-3_canfitebio.htm EX-99.3 1696
5 GRAPHIC ex99-1_001.jpg GRAPHIC 6929
6 GRAPHIC ex993_image1.jpg GRAPHIC 646567
7 GRAPHIC ex993_image2.jpg GRAPHIC 943342
  Complete submission text file 0001213900-20-016175.txt   2243527
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 20998608
SIC: 2834 Pharmaceutical Preparations